$1,000 invested Bristol-Myers Squibb (2023)
NYSE · BMY · reinvest dividends · adjusted close
●Result2023-01-03 — 2026-10-15
Today you would have
$979
-$21 (-2.14%)
BMYSPY (benchmark)
- Entry price
- $61.89
- Current price
- $60.57
- Shares
- 16.1569
- CAGR
- -0.57%
- Max Drawdown
- -43.48%
- vs SPY
- -113.54 pp
✦The story
A $1,000 investment in Bristol-Myers Squibb at the start of 2023 was worth $979 by mid-2026 — essentially flat at −2.1%. The drugmaker faced pressure from looming patent expirations on key medicines during this period. By contrast, the S&P 500 gained +111.4% over the same stretch.
#Related scenariosfor comparison
Other years for BMY